Literature DB >> 24217604

Angiogenic and antiangiogenic chemokines.

Daniela Bosisio1, Valentina Salvi, Vincenzo Gagliostro, Silvano Sozzani.   

Abstract

Chemokines are a family of vertebrate-specific, small-secreted molecules that were originally identified as mediators of leukocyte migration and tissue positioning during the immune response. Subsequently, chemokines were discovered to control movement also of endothelial cells and other cell types in many different contexts. The human chemokine system comprises about 50 chemokines and more than 20 receptors belonging to the seven-transmembrane receptor family. In the present chapter, we review the literature supporting a role for chemokines in angiogenesis and lymphangiogenesis. We highlight that chemokines exert both pro- and antiangiogenic roles either by acting directly on endothelial cells or by recruiting leukocytes that, in turn, secrete angiogenic mediators. This latter mode of action is possibly the most relevant in tumor angiogenesis. Finally, we explore the angiogenic properties of nonchemokine chemoattractant molecules.
Copyright © 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24217604     DOI: 10.1159/000353317

Source DB:  PubMed          Journal:  Chem Immunol Allergy        ISSN: 0079-6034


  17 in total

Review 1.  Angiogenesis and liver fibrosis.

Authors:  Gülsüm Özlem Elpek
Journal:  World J Hepatol       Date:  2015-03-27

2.  Gene expression profiles of HTR8-S/Vneo cells after changes in ABCA1 expression.

Authors:  Chengmao Xie; Xiaohui Cai; Xiaoju Wang; Li Lin; Yan Long; Xin Cui
Journal:  Funct Integr Genomics       Date:  2018-06-21       Impact factor: 3.410

Review 3.  The immune network in thyroid cancer.

Authors:  Maria Rosaria Galdiero; Gilda Varricchi; Gianni Marone
Journal:  Oncoimmunology       Date:  2016-03-30       Impact factor: 8.110

4.  Chronic inflammatory lesions of the placenta are associated with an up-regulation of amniotic fluid CXCR3: A marker of allograft rejection.

Authors:  Eli Maymon; Roberto Romero; Gaurav Bhatti; Piya Chaemsaithong; Nardhy Gomez-Lopez; Bogdan Panaitescu; Noppadol Chaiyasit; Percy Pacora; Zhong Dong; Sonia S Hassan; Offer Erez
Journal:  J Perinat Med       Date:  2018-02-23       Impact factor: 1.901

Review 5.  Advances in Research on the Effects and Mechanisms of Chemokines and Their Receptors in Cancer.

Authors:  Jing Xu; Jing-Quan Li; Qi-Lei Chen; Elena A Shestakova; Vsevolod A Misyurin; Vadim S Pokrovsky; Elena M Tchevkina; Hu-Biao Chen; Hang Song; Jian-Ye Zhang
Journal:  Front Pharmacol       Date:  2022-06-13       Impact factor: 5.988

6.  The anti-angiogenesis mechanism of Geniposide on rheumatoid arthritis is related to the regulation of PTEN.

Authors:  Yanhong Bu; Hong Wu; Ran Deng; Yan Wang
Journal:  Inflammopharmacology       Date:  2022-04-07       Impact factor: 5.093

7.  Regulation of Dipeptidyl Peptidase IV in the Post-stroke Rat Brain and In Vitro Ischemia: Implications for Chemokine-Mediated Neural Progenitor Cell Migration and Angiogenesis.

Authors:  Umadevi V Wesley; James F Hatcher; Emine R Ayvaci; Abby Klemp; Robert J Dempsey
Journal:  Mol Neurobiol       Date:  2016-08-15       Impact factor: 5.590

8.  Angiostatic, tumor inflammatory and anti-tumor effects of CXCL4(47-70) and CXCL4L1(47-70) in an EGF-dependent breast cancer model.

Authors:  Katrien Van Raemdonck; Nele Berghmans; Vincent Vanheule; Antonella Bugatti; Paul Proost; Ghislain Opdenakker; Marco Presta; Jo Van Damme; Sofie Struyf
Journal:  Oncotarget       Date:  2014-11-15

Review 9.  Targeting Chemokines and Chemokine Receptors in Melanoma and Other Cancers.

Authors:  Nicolas Jacquelot; Connie P M Duong; Gabrielle T Belz; Laurence Zitvogel
Journal:  Front Immunol       Date:  2018-10-29       Impact factor: 7.561

10.  Oral Supplementation with Baker's Yeast Beta Glucan Is Associated with Altered Monocytes, T Cells and Cytokines following a Bout of Strenuous Exercise.

Authors:  Brian K McFarlin; Adam S Venable; Katie C Carpenter; Andrea L Henning; Stephan Ogenstad
Journal:  Front Physiol       Date:  2017-10-20       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.